Psyomics lands Innovate UK loan to build regulated NHS mental health tools
What's the deal? UK healthtech Psyomics has secured an Innovation Loan from Innovate UKDealroom has a profile for this one. Try Dealroom → to develop regulated digital mental health technology for the NHS and the wider healthcare market.
What's the endgame? The debt finance will accelerate Psyomics' beseen™ platform into a regulated medical device. The company plans to bring three new products to market — Echo, Loop, and Compass — under a programme called "Scaling mental health care through intelligent clinical decision support tools."
What do the tools do? The three products aim to modernise mental health pathways by reducing paperwork, improving consistency in decision-making, and helping overstretched services work more efficiently. Psyomics, which already serves over 8 million adults, projects the tools will release 85,000 healthcare professional hours and deliver a 13.2x return for the NHS in year one.
Why now? The loan comes as demand for mental health support rises sharply across adult, children, and young people's services, while providers face workforce shortages and pressure to digitise legacy systems.
"This loan is a major endorsement of Psyomics' vision to modernise mental health care through safe, clinically robust digital innovation," said chief executive officer Dr. Melinda ReesDealroom has a profile for this one. Try Dealroom →. "It will enable us to place regulated medical devices on the market and bring powerful new capabilities to NHS services."
The signal: Debt finance from Innovate UK points to a broader push to modernise NHS infrastructure and intervene earlier, before mental health needs escalate. Psyomics' bet is that regulated clinical decision tools can ease waiting lists while building a scalable UK healthtech business.
Read more: Hub Publishing
Image credit: EU-Ukraine cooperation
